key: cord-0724706-iks62g79
authors: Grando, Rafael D.; Brentano, Vicente B.; Zanardo, Ana P.; Hertz, Felipe T.; Júnior, Luís C. Anflor; Prietto dos Santos, Jônatas F.; Galvão, Gabriela S.; Zavascki, Alexandre P.; Gazzana, Marcelo B.
title: Clinical Usefulness of Tomographic Standards for COVID-19 Pneumonia Diagnosis: Experience From a Brazilian Reference Center
date: 2020-10-31
journal: Braz J Infect Dis
DOI: 10.1016/j.bjid.2020.10.002
sha: 38b47d62b691912aa3a56ce2e588164501233442
doc_id: 724706
cord_uid: iks62g79

BACKGROUND: COVID-19 is a new disease and the most common complication is pneumonia. The Radiological Society of North America (RSNA) proposed an expert consensus for imaging classification for COVID-19 pneumonia. OBJECTIVE: To evaluate sensitivity, specificity, accuracy, and reproducibility of chest CT standards in the beginning of the Brazilian COVID-19 outbreak. METHODS: Cross-sectional study performed from March 1(st) to April 14(th), 2020. Patients with suspected COVID-19 pneumonia submitted to RT-PCR test and chest computed tomography (CT) were included. Two thoracic radiologists blinded for RT-PCR and clinical and laboratory results classified every patient scan according to the RSNA expert consensus. A third thoracic radiologist also evaluated in case of discordance, and consensus was reached among the three radiologists. A typical appearance was considered a positive chest CT for COVID-19 pneumonia. Sensitivity, specificity, positive and negative predictive values were calculated. Cohen’s kappa coefficient was used to evaluate intra- and inter-rater agreements. RESULTS: A total of 159 patients were included (mean age 57.9 ± 18.0 years; 88 [55.3%] males): 86 (54.1%) COVID-19 and 73 (45.9%) non-COVID-19 patients. Eighty (50.3%) patients had a positive CT for COVID-19 pneumonia. Sensitivity and specificity of typical appearance were 88.3% (95%CI, 79.9-93.5) and 94.5% (95%CI, 86.7-97.8), respectively. Intra- and inter-rater agreement were assessed (Cohen’s kappa = 0.924, P = 0.06; Cohen’s kappa=0.772, P = 0.05, respectively). CONCLUSION: Chest CT categorical classification of COVID-19 findings is reproducible and demonstrates high level of agreement with clinical and RT-PCR diagnosis of COVID-19. In RT-PCR scarcity scenarios or in equivocal cases, it may be useful for attending physicians in the evaluation of suspected COVID-19 pneumonia patients attended at the emergency unit.

Coronavirus Disease 2019 (COVID-19) is a transmissible respiratory disease that rapidly spread around the globe. Since the first case reported in February 2020, Brazil has been severely affected by the epidemic and was the second most affected country in the world, with over three million confirmed cases and more than a 100,000 deaths by the first days of August. 1, 2 Since the early stage of COVID-19 outbreak in China, chest computed tomography (CT) has been used in the evaluation of patients with suspected COVID-19 pneumonia in the emergency setting, even though it has not been recommended for routine screening or as an isolated diagnostic test. 3, 4 Although several radiological findings have been associated with COVID-19 pneumonia, [5] [6] [7] [8] [9] their presence in other diseases hamper CT's reliability for this specific diagnosis. 10 Chest CT specificity has broadly ranged in different studies, but the lack of standardized criteria impairs comparisons between them. 11 Tomographic standards, such as the Radiological Society of North America (RSNA) expert consensus, British Society of Thoracic Imaging guidance for radiological reporting and COVID-19 Reporting and Data System, have been proposed to overcome these limitations. [12] [13] [14] [15] [16] These proposed imaging classifications may help clinicians assess the likelihood of COVID-19 pneumonia before molecular test results are available or in settings where the access to these exams are limited.

So far, the majority of studies addressing the role of chest CT in the diagnosis of COVID-19 pneumonia evaluated its performance in Chinese or European populations. 12, 13, 16 The reproducibility of these findings may theoretically change across distinct regions of the globe due to potential differences in the affected population or circulating viruses. In this study, we aimed to evaluate sensitivity, specificity, accuracy, positive and negative predictive values and reproducibility of the RSNA imaging categories for COVID-19 pneumonia in patients evaluated at the emergency department of a referral center for COVID-19 patients in the early period of COVID-19 pandemic in Brazil.

The institutional review board approved the study and informed consent was waived. This was a cross-sectional study with patients presenting with fever or respiratory symptoms, from March 1 st to April 14 th , 2020, at a COVID-19 dedicated area in the emergency unit of a private hospital. All patients who collected a reverse transcriptase-polymerase chain reaction (RT-PCR) for the diagnosis of COVID-19 were eligible. The study included consecutive patients with suspected pneumonia that underwent che st CT, at the discretion of the attending physician. Chest CT was ordered according to the institutional protocol taking into account pneumonia severity criteria, laboratory tests and comorbidities.

Exclusion criteria were age <18 years, lack of data in medical records, and severe respiratory motion artifacts on chest CT. 

One oropharyngeal and two nasopharyngeal (from both nostrils) rayon swabs were collected. RNA extraction and real-time RT-PCR were performed at an external laboratory (Grupo Fleury), a reference private laboratory in Brazil, using primer and probes according to the Charité protocol, as previously described. 18 

Imaging acquisitions were obtained with patients in the supine position during endinspiration without contrast medium injection. Chest CT was performed on a 16 -slice CT 

All chest CT images were evaluated independently by two radiologists with two and 10 years of thoracic imaging experience. Both readers evaluated every patient scan twice with a 2-day interval between readout sessions to assess intra and inter-rater agreement. Discordant reports were evaluated by a third thoracic radiologist with 12 years of experience and consensus was reached among the three radiologists. All radiologists were blinded for RT-PCR, clinical and laboratory results, and previous imaging exams.

CT features were classified as "typical," "indeterminate," "atypical," and "negative" for COVID-19 pneumonia", according to RSNA expert consensus. 15 COVID-19 typical features are peripheral, bilateral and multifocal rounded ground-glass opacities (GGO) with or without consolidation or visible intralobular lines ("crazy-paving"). Reversed halo sign and J o u r n a l P r e -p r o o f other findings of organizing pneumonia can be seen later in the disease. Indeterminate features may occur but are nonspecific for COVID-19 pneumonia, such as diffuse, perihilar, or unilateral GGO. All unusual or unreported findings for COVID-19 were classified as atypical (e.g., centrilobular nodules, tree-in-bud opacities, or lung cavitation). If no CT suggestive findings of pneumonia were present, a negative classification was assigned. A typical appearance was considered a positive chest CT for COVID-19.

Statistical analysis was performed using SPSS version 18 prevalence were also estimated. A p<0.05 was considered statistically significant. (Table 1) . Age and sex were not significantly different between both groups. Anosmia was significantly more frequent in COVID-19

group. The non-COVID group had a shorter median duration of symptoms before attendance at emergency. COVID-19 patients had significantly lower oxygen saturation at emergency admission, lower leukocyte, lymphocyte, and platelets counts.

The median time between collecting nasal and oropharyngeal swabs and performing chest CT was 3.6 hours (IQR, 1.6-8.3), and the median time from onset of symptoms to undergoing CT was seven days (IQR, [3] [4] [5] [6] [7] [8] [9] . Eighty (93.0%) COVID-19 patients had their diagnosis confirmed in the first RT-PCR for SARS-CoV-2, while in 6 (7.0%) the first test was negative but the second was positive.

Chest CT features were classified as typical in 80 (50.3%) patients, as indeterminate in 30 Of these, according to their attendant physician, 13 had the final diagnos is of bacterial pneumonia, one had decompensated heart failure and three had no confirmed alternative diagnosis. The most common findings among these patients were centrilobular nodules (n=15) and tree-in-bud opacities (n=7) (Figure 4 ). Among patients with indeterminate appearance (n=30), seven had a positive RT-PCR for SARS-CoV-2. In this group, common findings were very few and non-rounded GGO (n=4), diffuse GGO (n=2), and unilateral features (n=1) ( Figure 5 ). One of them also had radiological features of pulmonary fibrosis.

A total of 26 (32.5%) patients with typical findings were tested for influenza by molecular methods (three of them for all other pathogens described in Methods; two were patients with negative SARS-CoV-2 RT-PCR) and none had positive results. Molecular tests for influenza were negative in other five (16.7%; one also negative for other pathogens), three (17.6%) and five (15.6%; one also negative for other pathogens) patients with indeterminate, atypical, and negative CT findings, respectively.

J o u r n a l P r e -p r o o f Intra-rater agreement in assigned classification was seen in 282 (88.7%) of 318 observations. Regarding intra-rater agreement, Cohen's kappa of observer one was 0.847 (P=.13), and observer two was 0.924 (P=.06). Inter-rater agreement ranged from 0.725 (P=.001) to 0.772 (P=.05) between two radiologists (see Tables S1 and S2). The agreement coefficients of selected typical findings are shown in Table S3 . specificity (84.8%) rates in that specific population. These results are comparable to those demonstrated in a recent study evaluating Italian patients, in which the authors used the same radiological criteria and found that a typical pattern had an specificity of 91.6% for COVID-19 pneumonia. 24 Other Chinese and Italian studies performed in the early COVID-19 pandemic showed much lower specificity rates (25.0% to 56.0%) for chest CT; 6, 25 However, those studies have not addressed the chest CT criteria proposed by RSNA, which may have affected their results owing to the lack of standards in CT interpretation. 6, 25 Finally, a recent meta-analysis found a pooled specificity of 37.0% for chest CT. 26 However, J o u r n a l P r e -p r o o f as considered by the authors, there was significant heterogeneity among the studies. 26 We believe that it was mostly caused by the fact that studies using non-standardized criteria for interpretation were included in the analysis.

Only four patients with typical CT findings were not diagnosed with COVID-19 by RT-PCR.

Although all had negative RT-PCRs, this diagnosis could not be ruled out in at least two of them, who had no alternative diagnosis during hospitalization ( Figure 6 ). Additionally, one patient had pulmonary embolism, which is a possible complication described in COVID-19

patients. 27 Other studies also showed similar findings related to some false negative RT -PCR results with typical chest CT appearance. 28 -31 A previous study has assessed the RSNA classification inter-rater reliability, with moderate to substantial agreement results. 32 Our study reinforces these findings, demonstrating an almost perfect intra-rater and substantial inter-rater agreements. These are encouraging outcomes, suggesting that the classification may be useful for clinicians to accurately estimate their suspicion for COVID-19 pneumonia before RT-PCR results become available and increase the confidence in imaging classification, especially in settings where molecular tests are restricted or unavailable. Actually, in pandemic scenarios where the expected COVID-19 prevalence in patients with respiratory symptoms is above 30%, the PPV of typical CT appearance was higher than 80%. Moreover, it was higher than 90% when the prevalence was above 40%, making imaging classification a reliable tool to identify highly suspicious cases of SARS-CoV-2 pneumonia.

Even though typical appearance sensitivity was near 90%, it is not possible to rule out the diagnosis with a non-typical appearance, particularly in the high prevalence scenario.

Previous studies suggested a high sensitivity for CT; however, the lack of clear definitions for positive CT findings impairs the generalizability of those findings. 25, 26, 33 On the other hand, it is important to highlight that the diagnosis of COVID-19 pneumonia was correctly excluded in all patients classified as atypical, suggesting that this classification may be Among typical findings, the most frequent were multifocal and rounded GGO, crazy-paving, and perilobular pattern, usually peripheral and bilateral. Interestingly, despite discordance among readers regarding some isolated typical CT signs, there was agreement in the final standard. It is noteworthy that each radiological finding should not be considered individually, considering that these features are not uniquely related to COVID-19 pneumonia. Even noninfectious diseases may present findings that might overlap with CT features related to SARS-CoV-2 infection, such as pulmonary edema, organizing pneumonia, drug-related toxicity, pulmonary infarcts, and interstitial lung diseases. 34 -37 Furthermore, coinfection with other viruses cannot be ruled out using only chest CT.

However, it is noteworthy that the study was conducted in a period before the influenza season in our region and, in addition to our data on molecular tests for influenza, it should be highlighted that, during the study period, only one case of severe acute respiratory syndrome caused by influenza was reported to the Municipal Health Secretary, in mid March and from another institution (https://opendatasus.saude.gov.br/dataset/bd-srag-2020).

Our study has limitations and must be interpreted accordingly. First, there was not a previously defined criteria for ordering RT-PCR and chest CT and, during the study period, RT-PCR was mostly collected from patients showing signs of moderate or severe d isease.

Therefore, COVID-19 patients presenting with mild disease and pneumonia could have been discharged with no further imaging and laboratory investigations. Second, it was a single-center experience with thorax-experienced radiologists, and scans readings may be less precise when evaluated by general radiologists. Third, our findings are applicable to patients with acute moderate and severe respiratory symptoms performing chest CT during J o u r n a l P r e -p r o o f a COVID-19 epidemic period. Finally, alternative diagnoses for non-COVID-19 patients were not fully evaluated in all patients. However, as discussed above, two of the four patients with "typical" appearance and negative RT -PCR were considered as nonlaboratory confirmed COVID-19 by attendant physicians before hospital discharge.

In conclusion, in patients with suspected COVID-19 pneumonia, chest CT categorical classification of COVID-19 findings is reproducible and demonstrates high agreement with clinical and RT-PCR diagnosis of COVID-19. Our study reinforces the role of tomographic standards to improve accuracy of radiological reports and to help physicians diagnosing COVID-19 pneumonia.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. a Considered as other findings of organizing pneumonia seen later in the disease.

An interactive web-based dashboard to track COVID-19 in real time

Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil

The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Chest CT Features of COVID-19 in

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China

Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias

Systematic Review and Meta-Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVID-19): Sol Scientiae, Illustra Nos

CO-RADS-A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation Original research

Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID19 Symptoms

Thoracic Imaging in COVID-19 Infection -Guidance for the Reporting Radiologist British Society of Thoracic Imaging -Version 2

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA

CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: A practical scoring method

Infectious DiseasesSociety of America guidelines on the diagnosis of COVID-19-Recommendation 6

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Design and Performance of the CDC Real-Time Reverse Transcriptase PCR Swine Flu Panel for Detection of 2009 A (H1N1) Pandemic Influenza Virus

Interrater reliability : the kappa statistic

What Is Coefficient Alpha? An Examination of Theory and Applications

Initial Results of the Use of a Standardized Diagnostic Criteria for Chest Computed Tomography Findings in Coronavirus Disease

Chest CT accuracy in the diagnosis of SARS-CoV-2 infection: initial experience in a cancer center

Diagnostic Accuracy of North America Expert Consensus Statement on Reporting CT Findings in Patients with Suspected COVID-19 Infection: An Italian Single Center Experience

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Hyunsook Hong SHY. Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis

Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to D-Dimer Levels

Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test

Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's Diagnostics Committee

Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Radiological Society of North America Chest CT Classification System for Reporting COVID-19 Pneumonia: Interobserver Variability and Correlation with RT-PCR. Radiol Cardiothorac Imaging

Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

COVID-19 pneumonia: A review of typical CT findings and differential diagnosis

From the Radiologic Pathology Archives: Organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia

Crazy-Paving" Pattern at Thin-Section CT of the Lungs: Radiologic-Pathologic Overview

Isolated diffuse ground-glass opacity in thoracic CT: Causes and clinical presentations

J o u r n a l P r e -p r o o f